402 Results

People

  1. Hudis
    Hudis
  2. Norton
    Norton
  3. Kelsen
    Kelsen
  4. Seidman
    Seidman
  5. Motzer
    Motzer
  6. Saltz
    Saltz
  7. Aghajanian
    Aghajanian
  8. Spriggs
    Spriggs
  9. Kemeny
    Kemeny
  10. Kris
    Kris

Groups

  1. Department of Medicine (247)
  2. Solid Tumor Oncology Division (212)
  3. Survivorship Research (83)
  4. Breast Medicine Service (70)
  5. Gastrointestinal Oncology Service (53)
  6. Genitourinary Oncology Service (50)
  7. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (49)
  8. Epidemiology and Biostatistics (49)
  9. Center for Pancreatic Cancer Research (44)
  10. Hematologic Malignancies, Division of (44)
  1. "drug administration schedule"
Formats
  1. Journal Article (392)
  2. Conference Paper (10)
Groups
  1. Department of Medicine (247)
  2. Solid Tumor Oncology Division (212)
  3. Survivorship Research (83)
  4. Breast Medicine Service (70)
  5. Gastrointestinal Oncology Service (53)
  6. Genitourinary Oncology Service (50)

More Groups

People
  1. Clifford Hudis (32)
  2. Larry Norton (30)
  3. Andrew Seidman (25)
  4. David Kelsen (25)
  5. Nancy Kemeny (24)
  6. Robert Motzer (24)

More People

Years
  1. 2024 (1)
  2. 2022 (1)
  3. 2021 (3)
  4. 2020 (1)
  5. 2019 (1)
  6. 2017 (7)

More Years

Publications
  1. Journal of Clinical Oncology (82)
  2. Cancer (34)
  3. Clinical Cancer Research (23)
  4. Seminars in Oncology (18)
  5. Gynecologic Oncology (16)
  6. JNCI: Journal of the National Cancer Institute (14)

More Publications

Publishers
  1. American Society of Clinical Oncology (83)
  2. Elsevier Inc. (62)
  3. Wiley Blackwell (39)
  4. American Association for Cancer Research (36)
  5. Oxford University Press (27)
  6. Springer (26)

More Publishers

Results (402)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Five-year outcomes of adjuvant carboplatin/paclitaxel chemotherapy and intravaginal radiation for stage I-II papillary serous endometrial cancer
    Journal Article

    Kiess, A. P.; Damast, S.; Makker, V.; Kollmeier, M. A.; Gardner, G. J.; Aghajanian, C.; Abu-Rustum, N. R.; Barakat, R. R.; Alektiar, K. M.
    Gynecologic Oncology (2012)

    Fulltext@MSK | Save
  • Phase I dose-escalation trial of clofarabine followed by escalating doses of fractionated cyclophosphamide in children with relapsed or refractory acute leukemias
    Journal Article

    Abd Elmoneim, A.; Gore, L.; Ricklis, R. M.; Boklan, J.; Cooper, T.; Narendran, A.; Rolla, K.; Scott, T.; Arceci, R. J.
    Pediatric Blood and Cancer (2012)

    Fulltext@MSK | Save
  • Development and validation of a prediction index for hand-foot skin reaction in cancer patients receiving sorafenib
    Journal Article

    Dranitsaris, G.; Vincent, M. D.; Yu, J.; Huang, L.; Fang, F.; Lacouture, M. E.
    Annals of Oncology (2012)

    Fulltext@MSK | Save
  • Randomized phase II trial of sunitinib on an intermittent versus continuous dosing schedule as first-line therapy for advanced renal cell carcinoma
    Journal Article

    Motzer, R. J.; Hutson, T. E.; Olsen, M. R.; Hudes, G. R.; Burke, J. M. ; Edenfield, W. J.; Wilding, G.; Agarwal, N.; Thompson, J. A.; Cella, D.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Prostate cancer risk in men with prostate and breast cancer family history: Results from the REDUCE study (R1)
    Journal Article

    Thomas, J. A.; Gerber, L.; Moreira, D. M.; Hamilton, R. J.; Bañez, L. L.; Castro-Santamaria, R.; Andriole, G. L.; Isaacs, W. B.; Xu, J.; Freedland, S. J.
    Journal of Internal Medicine (2012)

    Fulltext@MSK | Save
  • Active comparator-controlled, rater-blinded study of corticotropin-based immunotherapies for opsoclonus-myoclonus syndrome
    Journal Article

    Tate, E. D.; Pranzatelli, M. R.; Verhulst, S. J.; Markwell, S. J.; Franz, D. N.; Graf, W. D.; Joseph, S. A.; Khakoo, Y. N.; Lo, W. D.; Mitchell, W. G.; more...
    Journal of Child Neurology (2012)

    Fulltext@MSK | Save
  • Marked, homogeneous, and early [(18)F]fluorodeoxyglucose-positron emission tomography responses to vemurafenib in BRAF-mutant advanced melanoma
    Journal Article

    McArthur, G. A.; Puzanov, I.; Amaravadi, R.; Ribas, A.; Chapman, P.; Kim, K. B.; Sosman, J. A.; Lee, R. J.; Nolop, K.; Flaherty, K. T.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A phase I study of temsirolimus plus carboplatin plus paclitaxel for patients with recurrent or metastatic (R/M) head and neck squamous cell cancer (HNSCC)
    Journal Article

    Fury, M. G.; Sherman, E.; Ho, A.; Katabi, N.; Sima, C.; Kelly, K. W.; Nwankwo, O.; Haque, S.; Pfister, D. G.
    Cancer Chemotherapy and Pharmacology (2012)

    Fulltext@MSK | Save
  • Population pharmacokinetic analysis of 17-dimethylaminoethylamino-17- demethoxygeldanamycin (17-DMAG) in adult patients with solid tumors
    Journal Article

    Aregbe, A. O.; Sherer, E. A.; Egorin, M. J.; Scher, H. I.; Solit, D. B.; Ramanathan, R. K.; Ramalingam, S.; Belani, C. P.; Ivy, P. S.; Bies, R. R.
    Cancer Chemotherapy and Pharmacology (2012)

    Fulltext@MSK | Save
  • Short-term androgen deprivation therapy for patients with intermediate-risk prostate cancer undergoing dose-escalated radiotherapy: The standard of care?
    Journal Article

    Zumsteg, Z. S.; Zelefsky, M. J.
    Lancet Oncology (2012)

    Fulltext@MSK | Save